4 ms·

As a Canadian I wonder how available this new stuff is here.

by drpgq 3y ago

graypegg 3y ago
She lives in Oshawa Ontario, went to lakeridge health cancer centre. As for if this cancer screening process from the root post is available, I’m not sure.
arcticbull 3y ago
Cancer outcomes in Canada are approximately the same as in the US. Give or take. Some are better in Canada, some better in the US. > Conclusions: Among younger Canadian cancer patients in the lowest SES group, greater access to health care may have resulted in higher cancer survival, while higher screening prevalence and access to health insurance (Medicare) among older Americans during the period of this study may have resulted in higher survival for some screen-detected cancers. Higher survival in the highest SES group for stomach and liver may relate to treatment differences. [1] This study breaks it down by type, and socioeconomic status too, if you're curious. This is just one more recent study, but there's a lot of evidence to support this. [edit] Note that 5-year survival rate comparisons tend to benefit the US because the US does more aggressive testing. Studies show that this testing often doesn't actually reduce mortality, but it does start the 5-year survival clock earlier. So odds are this data overstates the outcomes in the US, particularly in the older demographic as the conclusion calls out. But that's a conversation for another time. [1] https://www.naaccr.org/wp-content/uploads/2022/07/NCRA-Spring-2022_v3.2_links_25-35-3.pdf https://www.naaccr.org/wp-content/uploads/2022/07/NCRA-Sprin...
- refurb 3y ago
  Wow, for things like prostate cancer, the 5-year survival rate in the US is 10% higher, even for the lowest SES.
  - arcticbull 3y ago
    For liver cancer it's about 15% higher in Canada for all SES, 10% higher for cervical cancers - and for all childhood cancers it's 5-10% higher in Canada depending on SES. For prostate cancer specifically, that's likely due to higher screening rate guidelines in the US leading to earlier detection, not lower mortality. Prostate cancer comes up a lot because it's often used as a stalking horse, and it's generally a disease of the elderly. [1] Specifically it came up in re: Guiliani and the UK: > For one thing, according to the American Cancer Society, many more men are screened for prostate cancer in the U.S. than in Britain. This leads to more cases being diagnosed. And many who have prostate cancer live for years, without treatment, whether they are diagnosed or not. Thus, a higher number of diagnoses leads to a higher official survival rate. But this tells us nothing about the quality of treatment available to those who have the disease. A spokesman for the ACS told us that comparing rates in the two countries is “misleading.” There have been evaluations of this between the US and Canada [2] > US and Canadian differences in screening due to guidelines can potentially explain cross-country differences in breast cancer mortality and affect interpretation of international comparisons of cancer statistics. The outcomes really are very comparable in the two systems, despite them trading top spots in different categories. [1] https://www.factcheck.org/2007/10/a-bogus-cancer-statistic/ https://www.factcheck.org/2007/10/a-bogus-cancer-statistic/ [2] https://academic.oup.com/intqhc/article/23/6/611/1819867 https://academic.oup.com/intqhc/article/23/6/611/1819867

As a Canadian I wonder how available this new stuff is here.

by drpgq 3y ago

As a Canadian I wonder how available this new stuff is here.

She lives in Oshawa Ontario, went to lakeridge health cancer centre. As for if this cancer screening process from the root post is available, I’m not sure.

arcticbull 3y ago

Cancer outcomes in Canada are approximately the same as in the US. Give or take. Some are better in Canada, some better in the US. > Conclusions: Among younger Canadian cancer patients in the lowest SES group, greater access to health care may have resulted in higher cancer survival, while higher screening prevalence and access to health insurance (Medicare) among older Americans during the period of this study may have resulted in higher survival for some screen-detected cancers. Higher survival in the highest SES group for stomach and liver may relate to treatment differences. [1] This study breaks it down by type, and socioeconomic status too, if you're curious. This is just one more recent study, but there's a lot of evidence to support this. [edit] Note that 5-year survival rate comparisons tend to benefit the US because the US does more aggressive testing. Studies show that this testing often doesn't actually reduce mortality, but it does start the 5-year survival clock earlier. So odds are this data overstates the outcomes in the US, particularly in the older demographic as the conclusion calls out. But that's a conversation for another time. [1] https://www.naaccr.org/wp-content/uploads/2022/07/NCRA-Spring-2022_v3.2_links_25-35-3.pdf https://www.naaccr.org/wp-content/uploads/2022/07/NCRA-Sprin...

refurb 3y ago
Wow, for things like prostate cancer, the 5-year survival rate in the US is 10% higher, even for the lowest SES.
- arcticbull 3y ago
  For liver cancer it's about 15% higher in Canada for all SES, 10% higher for cervical cancers - and for all childhood cancers it's 5-10% higher in Canada depending on SES. For prostate cancer specifically, that's likely due to higher screening rate guidelines in the US leading to earlier detection, not lower mortality. Prostate cancer comes up a lot because it's often used as a stalking horse, and it's generally a disease of the elderly. [1] Specifically it came up in re: Guiliani and the UK: > For one thing, according to the American Cancer Society, many more men are screened for prostate cancer in the U.S. than in Britain. This leads to more cases being diagnosed. And many who have prostate cancer live for years, without treatment, whether they are diagnosed or not. Thus, a higher number of diagnoses leads to a higher official survival rate. But this tells us nothing about the quality of treatment available to those who have the disease. A spokesman for the ACS told us that comparing rates in the two countries is “misleading.” There have been evaluations of this between the US and Canada [2] > US and Canadian differences in screening due to guidelines can potentially explain cross-country differences in breast cancer mortality and affect interpretation of international comparisons of cancer statistics. The outcomes really are very comparable in the two systems, despite them trading top spots in different categories. [1] https://www.factcheck.org/2007/10/a-bogus-cancer-statistic/ https://www.factcheck.org/2007/10/a-bogus-cancer-statistic/ [2] https://academic.oup.com/intqhc/article/23/6/611/1819867 https://academic.oup.com/intqhc/article/23/6/611/1819867